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Time-series methods are useful in quasi-experimental study designs in which rates of antibiotic-
resistant infections are ascertained before and after an intervention. However, uncertainties remain
regarding the use of time-series analysis as an appropriate research methodology for analysing the
effect of infection control interventions and antibiotic policies on the epidemiology of methicillin-
resistant Staphylococcus aureus (MRSA). In particular, there is still a substantial gap in our under-
standing of what actually happens to MRSA incidence when a planned intervention is made on use of
one or more antibiotic drug classes.
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In 1960, Berntsen and McDermott1 published a report demon-
strating that ‘The transmissibility of the staphylococci, principally
drug-resistant staphylococci, was considerably increased among
patients receiving therapy with an antimicrobial drug [tetra-
cycline]’. A few years later, Ehrenkranz2 provided further evi-
dence that the ‘spread of tetracycline-resistant Staphylococcus
aureus in man is enhanced by tetracycline treatment of the
carrier’. Since the publication of these landmark studies, a multi-
tude of observational studies using different study designs
have confirmed the effect of antibiotic selection pressure on
acquisition and transmission of methicillin-resistant S. aureus
(MRSA), especially in the healthcare setting.3 – 5 Taken together,
the evidence generated by these studies fulfils most of the criteria
outlined by McGowan6 for a causal relationship between
antibiotic use and MRSA rates: consistent associations, dose–
effect relationships, concomitant variations (changes in anti-
microbial use lead to parallel changes in incidence of MRSA),
and biological plausibility based on experimental models.
Many antibiotic classes used for common infectious conditions
are now ineffective against pandemic healthcare-associated MRSA
strains. Consequently, antibiotic treatment can have different nega-
tive ecological effects on MRSA acquisition, persistence and
transmission: (i) eradication of the susceptible skin flora including
coagulase-negative staphylococci will increase the likelihood of
MRSA acquisition, especially in healthcare settings with endemic
MRSA; (ii) antibiotics directly select for pre-existing MRSA in
carriers and enhance the likelihood of transmission; (iii) antibiotic
selection pressure may transform low-level carriers to persistent
high spreaders of MRSA; and (iv) antibiotics active against
methicillin-susceptible S. aureus (MSSA) may convert MSSA
carriers to non-carriers, indirectly promoting the spread of MRSA
within the population.7 Furthermore, at the level of the individual
host, antibiotic exposure may increase the risk of endogenous
MRSA infection related to changes in colonization resistance and
bacterial virulence.8
Despite this strong evidence for a causal link between
antibiotic selection pressure and MRSA incidence, surprisingly
few intervention studies have attempted to decrease MRSA rates
by active antibiotic policies.9 – 13 Table 1 summarizes selected
intervention studies published within the last 2 years, most of
them uncontrolled and of rather weak levels of evidence. The
intervention effects were not unidirectional, since several investi-
gations did not observe an impact of antibiotic control interven-
tions on MRSA rates.13,14 As a further important limitation, the
majority of these studies did not take into account the added
effect of pre-existing or newly introduced infection control
measures, such as active screening cultures or compliance with
standard precautions and hand hygiene guidelines. Not surpris-
ingly, a Cochrane review published in 2005 did not present
strong evidence to support MRSA control by antibiotic steward-
ship interventions.15
In this issue, two articles from Ireland and Switzerland
report interesting findings on the combined effect of antibiotic
use and infection control interventions on MRSA rates in their
hospitals. Although these two study groups were not aware of
each other’s analyses, they observed similar findings by using
comparable multivariate time-series models. Aldeyab et al.16
explained 79% of the variance in monthly MRSA incidence by
practices related to antibiotic use and infection control prac-
tices, including active screening cultures and use of alcohol-
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containing wipes and hand rubs. Vernaz et al.17 explained 57%
of the MRSA variance over time by analysing data on antibiotic
consumption, MRSA colonization pressure and alcohol-based
hand rubs. Interestingly, both studies found evidence of a role
of the usual suspects in driving MRSA acquisition and trans-
mission: fluoroquinolones, macrolides and broad-spectrum
cephalosporins. However, except for fluoroquinolones (anti-
biotic effect delayed for 1 month), the lag times between anti-
biotic use and changes in MRSA rates varied between 1 and 5
months. Limitations of the study by Vernaz et al.17 were the
lack of detailed data on the number of admission cultures,
whereas Aldeyab et al.16 were not able to include monthly data
on the use of alcohol-based hand rubs.
As in any good research, these studies are thought-provoking
and merit further discussion. Traditional epidemiological studies of
resistant organisms examine individual patient level associations
between antibiotic use and colonization or infection with resistant
organisms. In contrast, time-series methods rely on aggregated,
ecological level data. In the case of transmissible diseases, this
avoids the problem of erroneously assuming independence of
events and may also mitigate confounding. Time-series methods
are particularly useful in quasi-experimental study designs in
which infection rates have been ascertained before and after an
intervention.18 The interventions implemented in these two studies
related to infection control practices but not to antibiotic use. Thus,
the analysis of antibiotic use and MRSA incidence relied on
‘natural’ variation in antimicrobial use. However, because the
a priori hypotheses are less well-specified compared with the situ-
ation of a defined intervention, there may be a problem of multiple
statistical hypothesis testing. The fitted regression coefficients are
also not easily interpreted, in part because they are not translatable
into familiar measures of relative risk. As described above, there is
still a substantial gap in our understanding of what actually
happens to MRSA incidence when an intervention is made on the
use of one or more antibiotic drug classes.
Further studies are also required to better understand the
impact of interventions such as active surveillance cultures.
Aldeyab et al.16 suggest that active surveillance cultures
decreased MRSA incidence, in line with another recently pub-
lished time-series analysis.19 However, two recent high-quality
studies did not suggest that universal rapid screening was effec-
tive in reducing MRSA acquisition and infection.20,21 Thus,
more research is required to establish whether and for which
type of patients and settings MRSA screening offers more
benefit than other general preventive measures. Probably, inten-
sive promotion of alcohol-based hand rubs and behavioural
change interventions represent a more cost-effective approach
compared with universal screening policies.22 Several time-
series studies have now shown the immediate impact of
increased hand hygiene compliance and the use of alcohol-
based hand rubs, if properly promoted.16,17,23 – 25 Clearly, as
suggested by Aldeyab et al.,16 combined interventions are most
likely to be successful.
Moving forward, an emphasis on multi-institutional research is
required to tackle issues of generalizability and facility-to-facility
variation in baseline infection rates and hygiene practices.
Advancing the use of mechanistic models to improve the interpret-
ability and, possibly, validity, of statistical analyses of epidemiolo-
gical data is also important.26 Our ultimate goal is to understand
what works to prevent and control infections due to pathogens such
as MRSA and Clostridium difficile.T
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